Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Rose 41.7% in First Three Quarters of 2021

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 1.1 billion yuan in the first three quarters of 2021, up 41.7% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, up 12.3% year-on-year.

At the end of the reporting period, it had 6.3 billion yuan in total assets and 323.1 million yuan in total liabilities, with a liability-to-asset ratio of 5.1%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.